by Maggie Fox
EpiPens are in short supply in parts of the U.S., but people should still be able to find the emergency treatment for allergic reactions, federal health officials said Wednesday.
The Food and Drug Administration added EpiPens, generic epipens and Adrenaclick autoinjectors to its list of drug shortages. The FDA says there have been supply disruptions even though the maker, Mylan, is still making and distributing EpiPens and a generic version.
Click here for the full article.
Source: NBC News